The effect of motivational lung age feedback on short-term quit rates in smokers seeking intensive group treatment: A randomized controlled pilot study

Foulds, Jonathan; Veldheer, Susan; Hrabovsky, Shari; Yingst, Jessica; Sciamanna, Chris; Chen, Gang; Maccani, Jennifer Z.J.; Berg, Arthur

doi:10.1016/j.drugalcdep.2015.05.007

Cited by 17 publications

(34 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Nicotine dependence was assessed using 3 measures: Fagerstrom Test for Nicotine Dependence (FTND), 22 Hooked on Nicotine Checklist (HONC), 23,24 and the Penn State Cigarette Dependence Index (PSCDI). 25,26 The FTND is the most widely used method for assessing cigarette dependence. It includes 2 items (number of cigarettes smoked and time to first cigarette) that have become known as the Heaviness of Smoking Index (HSI) which are predictive of difficulty in quitting.…”

Section: Methodsmentioning

confidence: 99%

Acceptability of SPECTRUM Research Cigarettes among Participants in Trials of Reduced Nicotine Content Cigarettes

et al. 2018

Self Cite

View full text Add to dashboard Cite

Objectives SPECTRUM research cigarettes (SPECTRUMs) are being used in trials evaluating the effects of switching to reduced nicotine content (RNC) cigarettes. Because smokers have a high brand affinity, we evaluated if they were willing to switch and continue smoking normal nicotine content (NNC) SPECTRUMs. Methods We asked smokers (N = 341) to rate their own brand of cigarettes and NNC SPECTRUMs (after 2 weeks of use) using subjective measures including satisfaction, reward, taste, and craving reduction. We measured plasma cotinine, exhaled carbon monoxide (CO), and cigarettes per day (CPD), and recorded reasons for dropping out. Results After 2 weeks, 95% of participants chose to continue using SPECTRUMs for an additional 18 weeks. Moreover, 67% said SPECTRUMs were as good as or better than their own brand, and 65% said they would consider purchasing them. Ratings of satisfaction, reward, and craving reduction were 10%-15% lower on SPECTRUMs than on their own brand (p < .01). There were no differences in these ratings between menthol and non-menthol smokers. Conclusions Menthol and non-menthol SPECTRUMs are acceptable to smokers. Lower SPECTRUM ratings were likely due to brand switching and did not hinder study retention.

show abstract

Section: Methodsmentioning

confidence: 99%

Acceptability of SPECTRUM Research Cigarettes among Participants in Trials of Reduced Nicotine Content Cigarettes

et al. 2018

Self Cite

View full text Add to dashboard Cite

show abstract

“…A second model was then set up to include the intervention and any covariates from the first model that had a p value ≤.05. In addition, although the lung age feedback intervention for Part 1 of the study was not found to have an effect on short-term (1-month) abstinence (Foulds et al, 2015), it was included in this model to control for any possible effect. An identical procedure was followed for the secondary outcome that included all 225 participants, regardless of smoking status at 1 month.…”

Section: Study Design and Methodsmentioning

confidence: 99%

“…This report is Part 2 of a two-part randomized controlled clinical trial designed to help smokers quit smoking (Part 1) and stay quit (Part 2). Details of Part 1 have been reported elsewhere (Foulds et al, 2015). In brief, 225 participants aged 21 years or older who smoked >4 cigarettes per day and were ready to make a quit attempt in the next month participated in a 6-week smoking cessation trial designed to test the motivational effect of lung age feedback (at baseline assessment) on 1 month quit rates in smokers seeking intensive group treatment.…”

Section: Smoking Cessation Treatment Phase: Partmentioning

confidence: 99%

The Use of Self-Directed Relapse Prevention Booklets to Assist in Maintaining Abstinence After a 6-Week Group Smoking Cessation Treatment Program: A Randomized Controlled Trial

et al. 2017

Self Cite

View full text Add to dashboard Cite

show abstract

“…Results from these studies are mixed. Foulds et al [ 19 ] assessed outcomes 28 days after target quit date in 225 smokers randomized to receive motivational “Lung Age” feedback (exhaled CO values and forced expiratory volume over 1 second) versus minimal feedback. All participants were offered 6 weekly group coaching sessions and nicotine patches.…”

Section: Introductionmentioning

confidence: 99%

Assessment of a Personal Interactive Carbon Monoxide Breath Sensor in People Who Smoke Cigarettes: Single-Arm Cohort Study

Marler¹,

Fujii²,

Wong³

et al. 2020

J Med Internet Res

View full text Add to dashboard Cite

Background Tobacco use is the leading cause of preventable morbidity and mortality. Existing evidence-based treatments are underutilized and have seen little recent innovation. The success of personal biofeedback interventions in other disease states portends a similar opportunity in smoking cessation. The Pivot Breath Sensor is a personal interactive FDA-cleared (over-the-counter) device that measures carbon monoxide (CO) in exhaled breath, enabling users to link their smoking behavior and CO values, and track their progress in reducing or quitting smoking. Objective The objective of this study is to assess the Pivot Breath Sensor in people who smoke cigarettes, evaluating changes in attitudes toward quitting smoking, changes in smoking behavior, and use experience. Methods US adults (18-80 years of age, ≥10 cigarettes per day [CPD]) were recruited online for this remote 12-week study. Participants completed a screening call, informed consent, and baseline questionnaire, and then were mailed their sensor. Participants were asked to submit 4 or more breath samples per day and complete questionnaires at 1-4, 8, and 12 weeks. Outcomes included attitudes toward quitting smoking (Stage of Change, success to quit, and perceived difficulty of quitting), smoking behavior (quit attempts, CPD reduction, and 7-, 30-day point prevalence abstinence [PPA]), and use experience (impact and learning). Results Participants comprised 234 smokers, mean age 39.9 (SD 11.3) years, 52.6% (123/234) female, mean CPD 20.3 (SD 8.0). The 4- and 12-week questionnaires were completed by 92.3% (216/234) and 91.9% (215/234) of participants, respectively. Concerning attitude outcomes, at baseline, 15.4% (36/234) were seriously thinking of quitting in the next 30 days, increasing to 38.9% (84/216) at 4 weeks and 47.9% (103/215) at 12 weeks (both P<.001). At 12 weeks, motivation to quit was increased in 39.1% (84/215), unchanged in 54.9% (118/215), and decreased in 6.0% (13/215; P<.001). Additional attitudes toward quitting improved from baseline to 12 weeks: success to quit 3.3 versus 5.0 (P<.001) and difficulty of quitting 2.8 versus 4.3 (P<.001). Regarding smoking behavior, at 4 weeks, 28.2% (66/234) had made 1 or more quit attempts (≥1 day of abstinence), increasing to 48.3% (113/234) at 12 weeks. At 4 weeks, 23.1% (54/234) had reduced CPD by 50% or more, increasing to 38.5% (90/234) at 12 weeks. At 12 weeks, CPD decreased by 41.1% from baseline (P<.001), and 7- and 30-day PPA were 12.0% (28/234) and 6.0% (14/234), respectively. Concerning use experience, 75.3% (171/227) reported the sensor increased their motivation to quit. More than 90% (>196/214) indicated the sensor taught them about their CO levels and smoking behavior, and 73.1% (166/227) reported that seeing their CO values made them want to quit smoking. Conclusions Use of the Pivot Breath Sensor resulted in a significant increase in motivation to quit, a reduction in CPD, and favorable quit attempt rates. These outcomes confer increased likelihood of quitting smoking. Accordingly, the results support a role for biofeedback via personal CO breath sampling in smoking cessation. Trial Registration ClinicalTrials.gov NCT04133064; https://clinicaltrials.gov/ct2/show/NCT04133064

show abstract

The effect of motivational lung age feedback on short-term quit rates in smokers seeking intensive group treatment: A randomized controlled pilot study

Cited by 17 publications

References 24 publications

Acceptability of SPECTRUM Research Cigarettes among Participants in Trials of Reduced Nicotine Content Cigarettes

Acceptability of SPECTRUM Research Cigarettes among Participants in Trials of Reduced Nicotine Content Cigarettes

The Use of Self-Directed Relapse Prevention Booklets to Assist in Maintaining Abstinence After a 6-Week Group Smoking Cessation Treatment Program: A Randomized Controlled Trial

Assessment of a Personal Interactive Carbon Monoxide Breath Sensor in People Who Smoke Cigarettes: Single-Arm Cohort Study

Contact Info

Product

Resources

About